7th Annual Neuromuscular Disorders Seminar
General neurologists need periodic and regular updates about many hot topics in neuromuscular disorders. Evidence-based literature grows by the day and indications and contraindications change. Also, new medications are emerging and approved regularly which exacerbates the need to learn about their place in the treatment paradigm and to navigate the high-price dilemma. There is also a need to broaden the scope of the general neurologists on the emerging literature of new procedures such as skin biopsy and cervical spine surgery. There is growing literature on neuropathy and emerging therapies in myopathy which need to be addressed. This seminar is designed to have national and world experts talk about emerging therapies and updates on different neuromuscular disorders such as neuropathies, myopathies, amyotrophic lateral sclerosis, and myasthenia gravis.
Several new medications were approved for treatment of different neuromuscular disorders over the last 2 years. This seminar focusses primarily on drugs that are approved or still in the pipeline for treatment of muscle, nerve, and neuromuscular junction disorders and their place in the current and future treatment paradigm. Potential barriers, such as prohibitive cost, will be discussed. The seminar will highlight diagnostic approaches to disorders of muscles and nerves including expert analysis of the role of electromyography, muscle biopsy and nerve biopsy. In addition, indications and utility of these procedures will be discussed.
Designed for individuals interested in learning about new advances in the diagnosis and treatment of neuromuscular disorders, who are primarily neurologists, physiatrists, physician assistants, nurses, neurology fellows, residents, and students.
At the conclusion of this activity, the participant should be able to:
- Identify indications and side effects of new generation drugs to treat neuromuscular disorders.
- Recognize the importance of balancing the benefit and cost of the new therapies for neuromuscular disorders.
- Utilize EMG, muscle biopsy and skin biopsy for the diagnosis of disorders of muscles and nerves.
- Apply indications of surgery to patients with cervical and LS spondylosis.
Lecture and Case Study
Evaluation by questionnaire will address program content, presentation, and possible bias.
AMA PRA Category 1 Credits™
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Pathology (ABPath)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.00 Lifelong Learning MOC points in the American Board of Pathology's (ABPath) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABPath MOC credit.
- 7.00 ABPath MOC II
- 7.00 AMA PRA Category 1 Credit™
- 7.00 Attendance
Please register for this course at the following link: https://web.cvent.com/event/4f8dfb16-4e02-4f69-b64e-aabed20fae7a/regProcessStep1
Your profile will need to be complete in order to complete the evaluation and claim credit following the conference.
If you do not already have a profile, please click the links below for step-by-step instructions for setting up your profile: